澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

EPSILON HEALTHCARE LTD

0.027

+0.0028.00%

成交量：6.27萬

成交額：1,688

市值：1,050.58萬

市盈率：200

高：0.027

開：0.025

低：0.025

收：0.025

52周最高：0.040

52周最低：0.019

股本：3.89億

流通股本：2.70億

量比：0.15

換手率：0.02%

股息：- -

股息率：- -

每股收益(TTM):0.000

每股收益(LYR):-0.003

淨資產收益率：50.27%

總資產收益率：-5.29%

市淨率：2.71

市盈率(LYR):-7.94

資料載入中...

總覽公司新聞公告

概念

大麻概念-0.28%

資金流向

資金流入：

資金流出：

新聞

Epsilon Healthcare：旗下Epsilon Pharma初始三年期製造業務收入預期達600萬澳元

Epsilon Healthcare Ltd旗下Epsilon Pharma與Puro New Zealand達成製造協議助力歐洲市場拓展

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/EPN.AU"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"EPN.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"EPN.AU\",,,,,undefined,":{"symbol":"EPN.AU","market":"AU","secType":"STK","nameCN":"EPSILON HEALTHCARE LTD","latestPrice":0.027,"timestamp":1789107120000,"preClose":0.025,"halted":0,"volume":62709,"delay":0,"changeRate":0.07999999999999993,"nameEN":"EPSILON HEALTHCARE LTD","floatShares":269789980,"shares":389104011,"eps":0.000135,"marketStatus":"休市中","change":0.002,"latestTime":"09-11 16:12:00 AEST","open":0.025,"high":0.027,"low":0.025,"amount":1688,"amplitude":0.08,"askPrice":0.027,"askSize":140000,"bidPrice":0.025,"bidSize":296182,"shortable":3,"etf":0,"ttmEps":0.000135,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1789344000000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.025,"openAndCloseTimeList":[[1789084800000,1789106400000]],"volumeRatio":0.14922435885337665,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"EPN.AU","preClose":0.024,"auctionPrice":0.023,"auctionVolume":86257,"auction":3,"marketStatus":"盘后竞价","timestamp":1788329028820}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"EPN.AU\",,,,,undefined,":{"symbol":"EPN.AU","floatShares":269789980,"roa":"-5.29%","roe":"50.27%","lyrEps":-0.0034,"volumeRatio":0.14922435885337665,"shares":389104011,"dividePrice":0,"high":0.027,"amplitude":0.08,"preClose":0.025,"low":0.025,"week52Low":0.019,"pbRate":"2.71","psRate":"0.77","week52High":0.04,"institutionHeld":0,"latestPrice":0.027,"committee":0.358066,"eps":0.000135,"divideRate":0,"volume":62709,"delay":0,"ttmEps":0.000135,"open":0.025,"prevYearClose":0.033,"prevWeekClose":0.026,"prevMonthClose":0.021,"prevQuarterClose":0.022,"fiveDayClose":0.026,"twentyDayClose":0.022,"sixtyDayClose":0.022},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EPN.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EPN.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EPN.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1175470333","title":"Epsilon Healthcare：旗下Epsilon Pharma初始三年期製造業務收入預期達600萬澳元","url":"https://stock-news.laohu8.com/highlight/detail?id=1175470333","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175470333?lang=zh_tw&edition=fundamental","pubTime":"2026-02-05 08:13","pubTimestamp":1770250404,"startTime":"0","endTime":"0","summary":"Epsilon Healthcare Ltd (ASX: EPN) 宣布，其子公司Epsilon Pharma在为期三年的初始合作期内，预计制造业务收入将达到600万澳元。这一预测凸显了公司在医药制造领域的增长潜力和业务稳定性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7502","EPN.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171456716","title":"Epsilon Healthcare Ltd旗下Epsilon Pharma與Puro New Zealand達成製造協議 助力歐洲市場拓展","url":"https://stock-news.laohu8.com/highlight/detail?id=1171456716","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171456716?lang=zh_tw&edition=fundamental","pubTime":"2026-02-05 08:13","pubTimestamp":1770250398,"startTime":"0","endTime":"0","summary":"Epsilon Healthcare Ltd宣布，其子公司Epsilon Pharma已与新西兰企业Puro New Zealand签订新的制造合作协议。此项合作旨在为Epsilon Pharma在欧洲市场的扩张提供战略支持，通过强化供应链与本地化生产能力，提升其医药产品在欧洲的供应效率与市场竞争力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7502","EPN.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/EPN.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"大麻概念","id":"package_au_concept_dmgn","bkCode":"BK7502","changeRate":-0.002799}]}}